Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Sumitomo Pharma America, Inc.
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center